GZMB and Miyoshi myopathy: The ligands for DNAM-1 (CD155, CD112) are highly expressed in primary MM cells (Figure 2D), and co-culture with HD-ILC2s resulted in the production of GZMB by ILC2s, which was abrogated in the presence of the DNAM-1-blocking antibody (Figure 2E).